Squamous Cell Carcinoma of the Bladder
📧 Sign up to get email alerts when something new happens for Squamous Cell Carcinoma of the Bladder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C... [Phase 2]
A Phase 2 clinical trial (SMART) is assessing sacituzumab govitecan with or without atezolizumab in rare genitourinary tumors and is current…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Enfortumab Vedotin With or Without Pembrolizumab in Rare Genitourinary Tumors (E-VIRTUE) [Phase 2]
Phase 2 trial (E-VIRTUE) evaluating enfortumab vedotin with or without pembrolizumab in rare genitourinary tumors is currently recruiting, i…
-
CLINICAL_TRIALS trial_result · 2021-12-01Clinical Trial Update: Evaluating Immune Therapy, Durvalumab (MEDI4736) With Tremelimumab for Metastatic, Non-transitional Cell Carcinoma of the Urinary Tract [Phase 2]
Phase 2 trial evaluating durvalumab with tremelimumab for metastatic non-transitional cell carcinoma of the urothelial tract shows completed…
-
CLINICAL_TRIALS trial_result · 2013-01-14Clinical Trial Update: Trastuzumab and Combination Chemotherapy in Treating Patients With Locally Recurrent or Metastatic Urinary Tract Cancer [Phase 2]
Phase 2 clinical trial evaluating trastuzumab with chemotherapy in locally recurrent or metastatic urinary tract cancers has completed, incl…